Past CureTalks
COVID 19 pandemic is here. What to expect?
COVID 19 is now a global pandemic.The cases of coronavirus are increasing rapidly across the world with the count crossing 246,005 globally and increasing every day. The virus, which originated from China, has rapidly spread to about 160 countries.This is…
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers by Cellectar Biosciences. It works by delivering a radioactive, toxic compound directly to tumor…
Latest in Brain Tumor Treatments and Trials
Brain tumors can be among the most challenging cancers to treat. The blood-brain barrier, a natural defense mechanism that shields the brain from harm can also prevent cancer treatments from reaching tumors. However, immunotherapy, precision medicine, and the other new…
Making Infertility Treatments Affordable – Insurance Policies Related to Benefits
Soaring costs of infertility treatments and preservation burn holes in the pockets of patients already dealing with the emotional upheavals of it. Insurance coverage for infertility treatment is scarce and confusing, and is important to thoroughly understand the covered benefits…
ASH 2019 Annual Meeting Multiple Myeloma Updates
The 62nd ASH (American Society of Hematology) annual meeting was held in early December 2019. We are talking to Dr Shaji Kumar about new research presented at ASH, including disease-specific treatment updates on multiple myeloma, the role of precision medicine & clinical…